ERK1/2 pro-survival signalling is suppressed by pirtobrutinib in ibrutinib-resistant MYD88-mutated lymphoma cells. - Munshi M; Liu X; Kofides A; Tsakmaklis N; Hunter ZR; Guerrera ML; Canning A; Gustine JN; Liu S; Hatcher JM; Chen J; Meid K; et al. (British journal of haematology, 2024)